Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123062604 | 12306260 | 4 | F | 20160412 | 20160628 | 20160426 | 20160708 | EXP | JP-OTSUKA-2016_008497AA | OTSUKA | 78.86 | YR | M | Y | 0.00000 | 20160708 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123062604 | 12306260 | 1 | PS | SAMSCA | TOLVAPTAN | 1 | Oral | 7.5 MG, DAILY DOSE | U | 22275 | 7.5 | MG | TABLET | ||||||
| 123062604 | 12306260 | 2 | SS | SAMSCA | TOLVAPTAN | 1 | Oral | 7.5 MG, DAILY DOSE | U | 22275 | 7.5 | MG | TABLET | ||||||
| 123062604 | 12306260 | 3 | SS | SAMSCA | TOLVAPTAN | 1 | Oral | 3.75 MG, QD, AFTER BREAKFAST | U | 22275 | 3.75 | MG | TABLET | QD | |||||
| 123062604 | 12306260 | 4 | SS | LUPRAC | TORSEMIDE | 1 | Oral | 8 MG, DAILY DOSE | 0 | 8 | MG | TABLET | |||||||
| 123062604 | 12306260 | 5 | SS | LUPRAC | TORSEMIDE | 1 | Oral | 8 MG, QD, AFTER BREAKFAST | U | 0 | 8 | MG | TABLET | QD | |||||
| 123062604 | 12306260 | 6 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 20 MG, DAILY DOSE | 0 | 20 | MG | INJECTION | |||||||
| 123062604 | 12306260 | 7 | C | EFIENT | PRASUGREL HYDROCHLORIDE | 1 | Oral | 3.75 MG, QD, AFTER BREAKFAST | 0 | 3.75 | MG | FILM-COATED TABLET | QD | ||||||
| 123062604 | 12306260 | 8 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, QD, AFTER BREAKFAST | 0 | 100 | MG | FILM-COATED TABLET | QD | ||||||
| 123062604 | 12306260 | 9 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5 MG, QD, AFTER BREAKFAST | 0 | 5 | MG | FILM-COATED TABLET | QD | ||||||
| 123062604 | 12306260 | 10 | C | IMIDAPRIL HYDROCHLORIDE OHARA | 2 | Oral | 5 MG, QD, AFTER BREAKFAST | 0 | 5 | MG | TABLET | QD | |||||||
| 123062604 | 12306260 | 11 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD, AFTER BREAKFAST | 0 | 5 | MG | ORODISPERSIBLE TABLET | QD | ||||||
| 123062604 | 12306260 | 12 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 2.5 MG, QD, AFTER BREAKFAST | 0 | 2.5 | MG | FILM-COATED TABLET | QD | ||||||
| 123062604 | 12306260 | 13 | C | LANSOPRAZOLE TEVA | LANSOPRAZOLE | 1 | Oral | 15 MG, QD, AFTER BREAKFAST | 0 | 15 | MG | ORODISPERSIBLE TABLET | QD | ||||||
| 123062604 | 12306260 | 14 | C | FELBINAC | FELBINAC | 1 | Transdermal | UNK, QD, ON LOW BACK | 0 | TRANSDERMAL PATCH | QD | ||||||||
| 123062604 | 12306260 | 15 | C | RIBALL | ALLOPURINOL | 1 | Oral | 100 MG, QD, AFTER BREAKFAST | 0 | 100 | MG | TABLET | QD | ||||||
| 123062604 | 12306260 | 16 | C | TAMSULOSIN HYDROCHLORIDE NISSIN | 2 | Oral | 0.2 MG, QD, AFTER BREAKFAST | 0 | .2 | MG | ORODISPERSIBLE TABLET | QD | |||||||
| 123062604 | 12306260 | 17 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 990 MG, TID, AFTER EACH MEAL | 0 | 330 | MG | TABLET | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123062604 | 12306260 | 1 | Cardiac failure congestive |
| 123062604 | 12306260 | 4 | Product used for unknown indication |
| 123062604 | 12306260 | 5 | Product used for unknown indication |
| 123062604 | 12306260 | 6 | Product used for unknown indication |
| 123062604 | 12306260 | 7 | Product used for unknown indication |
| 123062604 | 12306260 | 8 | Product used for unknown indication |
| 123062604 | 12306260 | 9 | Product used for unknown indication |
| 123062604 | 12306260 | 10 | Product used for unknown indication |
| 123062604 | 12306260 | 11 | Product used for unknown indication |
| 123062604 | 12306260 | 12 | Product used for unknown indication |
| 123062604 | 12306260 | 13 | Product used for unknown indication |
| 123062604 | 12306260 | 14 | Product used for unknown indication |
| 123062604 | 12306260 | 15 | Product used for unknown indication |
| 123062604 | 12306260 | 16 | Product used for unknown indication |
| 123062604 | 12306260 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123062604 | 12306260 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123062604 | 12306260 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123062604 | 12306260 | 1 | 20160315 | 20160406 | 0 | |
| 123062604 | 12306260 | 2 | 201604 | 0 | ||
| 123062604 | 12306260 | 4 | 20160112 | 0 | ||
| 123062604 | 12306260 | 6 | 20160312 | 20160316 | 0 |